Who has invested in Protembis?

XGEN Venture, Tech Vision Fonds, Segulah Medical Acceleration, Coparion are named among the investors backing Protembis.

Protembis Funding: $64M Raised, Series B (2024)

Protembis funding overview

Protembis is based in Aachen, Germany. Protembis has raised $64M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in March 2024. The round record for Protembis runs through 2024; nothing later has been disclosed. Investors on record include XGEN Venture, Tech Vision Fonds, Segulah Medical Acceleration, Coparion. 4 distinct backers are named across the disclosed rounds.

Protembis at a glance

Total raised: $64M
Latest round: Series B
Latest round date: March 2024
Headquarters: Aachen, Germany
Notable investors: XGEN Venture, Tech Vision Fonds, Segulah Medical Acceleration, Coparion

Frequently asked about Protembis funding

How much has Protembis raised?: Protembis has raised $64M in total disclosed funding across the rounds on record.
Who has invested in Protembis?: XGEN Venture, Tech Vision Fonds, Segulah Medical Acceleration, Coparion are named among the investors backing Protembis.
What was the latest Protembis funding round?: The most recent disclosed round is a Series B, announced in March 2024.
Where is Protembis based?: Protembis is based in Aachen, Germany.
When did Protembis last raise?: The last disclosed Protembis round closed in March 2024 at Series B.

Protembis totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Aachen below to benchmark round size and investor mix.

Protembis Funding: $64M Raised, Series B (2024)

Protembis funding overview

Protembis at a glance

Frequently asked about Protembis funding

Companies related to Protembis (36)

Browse related funding lists (3)